Obbligazione Barclay PLC 3% ( US06741TWA14 ) in USD

Emittente Barclay PLC
Prezzo di mercato 100 USD  ▼ 
Paese  Regno Unito
Codice isin  US06741TWA14 ( in USD )
Tasso d'interesse 3% per anno ( pagato 2 volte l'anno)
Scadenza 19/06/2023 - Obbligazione è scaduto



Prospetto opuscolo dell'obbligazione Barclays PLC US06741TWA14 in USD 3%, scaduta


Importo minimo 1 000 USD
Importo totale 581 000 USD
Cusip 06741TWA1
Standard & Poor's ( S&P ) rating A ( Upper medium grade - Investment-grade )
Moody's rating N/A
Descrizione dettagliata Barclays PLC è una banca multinazionale britannica che offre una vasta gamma di servizi finanziari a clienti privati, aziende e istituzioni in tutto il mondo.

The Obbligazione issued by Barclay PLC ( United Kingdom ) , in USD, with the ISIN code US06741TWA14, pays a coupon of 3% per year.
The coupons are paid 2 times per year and the Obbligazione maturity is 19/06/2023
The Obbligazione issued by Barclay PLC ( United Kingdom ) , in USD, with the ISIN code US06741TWA14, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency.







http://www.sec.gov/Archives/edgar/data/312070/000110465913049640/...
424B2 1 a13-14454_16424b2.htm 424B2 - - 10Y STEP UP

CALCULATION OF REGISTRATION FEE

Title of Each Class of Securities Offered
Maximum Aggregate Offering Price
Amount of Registration Fee(1)







Global Medium-Term Notes, Series A
$581,000
$79.25



(1)
Calculated in accordance with Rule 457(r) of the Securities Act of 1933.


1 of 8
6/17/2013 4:00 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465913049640/...

Pricing supplement dated June 14, 2013
Filed Pursuant to Rule 424(b)(2)
(To Prospectus dated August 31, 2010 and
Registration No. 333-169119
the Prospectus Supplement dated May 27, 2011)


US$581,000
STEP-UP FIXED RATE CALLABLE NOTES DUE JUNE 19, 2023

Principal Amount:
US$581,000
Issuer:
Barclays Bank PLC

Issue Price:
Variable Price Re-Offer
Series:
Global Medium-Term Notes, Series A


Original Issue Date:
June 19, 2013
Payment at Maturity:
If you hold the Notes to maturity, you wil
receive 100% of your principal, subject to the
creditworthiness of Barclays Bank PLC. The
Notes are not, either directly or indirectly, an
obligation of any third party, and any payment
to be made on the Notes, including any
principal protection provided at maturity,
depends on the ability of Barclays Bank PLC
to satisfy its obligations as they come due.

Interest Rate Type:
Fixed Rate
Original Trade Date:
June 14, 2013

Maturity Date:
June 19, 2023, subject to Redemption at the
CUSIP:
06741TWA1
Option of the Company (as set forth below).

ISIN:
US06741TWA14
Denominations:
Minimum denominations of US$1,000 and
Business Day:
x New York

integral multiples of US$1,000 thereafter.
x London

o
Euro

o
Other (_________________)


Interest Rate:
· For each Interest Period commencing on the Original Issue Date, to but excluding June 19, 2019, the interest rate per annum wil be
equal to: 2.75%
· For each Interest Period commencing on June 19, 2019, to but excluding June 19, 2021, the interest rate per annum wil be equal to:
3.00%
· For each Interest Period commencing on June 19, 2021, to but excluding June 19, 2022, the interest rate per annum wil be equal to:
4.00%
· For each Interest Period commencing on June 19, 2022, to but excluding the Maturity Date, the interest rate per annum wil be equal to:
5.00%

Interest Payment Dates:
o Monthly, o Quarterly, x Semi-Annual y, o Annual y,

payable in arrears on the 19
th day of each June and December, commencing on December 19, 2013 and ending on the Maturity Date or the Early
Redemption Date, if applicable.

Business Day Convention:
Fol owing, Unadjusted
Day Count Convention:
30/360


[Terms of Note continue on the fol owing page]

Barclays Capital Inc. has agreed to purchase the Notes from us at 100% of the principal amount minus a commission equal to $15.00 per $1,000 principal amount, or 1.50%, resulting in
aggregate proceeds to Barclays Bank PLC of $572,285. Barclays Capital Inc. proposes to offer the Notes from time to time for sale in negotiated transactions, or otherwise, at varying prices
to be determined at the time of each sale. See "Risk Factors--The price you pay for the Notes may be higher than the prices other investors pay for the Notes." on page PS-1 of this pricing
supplement. Barclays Capital Inc. may also use all or a portion of its commissions on the Notes to pay sel ing concessions or fees to other dealers. Barclays Capital Inc. may also use all or a
portion of its commissions on the Notes to pay sel ing concessions or fees to other dealers.

Any payment on the Notes is subject to the creditworthiness of the Issuer and is not guaranteed by any third party. For a description of risks with respect to the ability of Barclays Bank PLC
to satisfy its obligations as they come due, see "Issuer Credit Risk" in this pricing supplement.

Investing in the Notes involves a number of risks. See "Risk Factors" beginning on page S-6 of the prospectus supplement and "Selected Risk Factors" below.

The Notes wil not be listed on any U.S. securities exchange or quotation system. Neither the Securities and Exchange Commission nor any state securities commission has approved or
disapproved of these securities or determined that this pricing supplement is truthful or complete. Any representation to the contrary is a criminal offense.

Interest Period:
The initial Interest Period wil begin on, and include, the Original Issue Date and end on, but exclude, the first Interest Payment Date. Each
subsequent Interest Period wil begin on, and include, the Interest Payment Date for the immediately preceding Interest Period and end on, but
exclude, the next fol owing Interest Payment Date. The final Interest Period wil end on, but exclude, the Maturity Date (or the Early Redemption
Date, if applicable).

Redemption at the Option of the
We may redeem your Notes, in whole or in part, at the Redemption Price set forth below, on any Interest Payment Date commencing on June 19,
Company:
2014, provided we give at least five business days' prior written notice to the trustee. If we exercise our redemption option, the Interest Payment
Date on which we so exercise wil be referred to as the "Early Redemption Date".

Redemption Price:
If we exercise our redemption option, you wil receive on the Early Redemption Date 100% of the principal amount together with any accrued and
unpaid interest to but excluding the Early Redemption Date.

Settlement:
DTC; Book-entry; Transferable.

Listing:
The Notes wil not be listed on any U.S. securities exchange or quotation system.



The Notes constitute our direct, unconditional, unsecured and unsubordinated obligations and are not deposit liabilities of Barclays Bank PLC and are not insured by the U.S.
Federal Deposit Insurance Corporation or any other governmental agency of the United States, the United Kingdom or any other jurisdiction.

We may use this pricing supplement in the initial sale of Notes. In addition, Barclays Capital Inc. or another of our affiliates may use this pricing supplement in market resale
transactions in any Notes after their initial sale. Unless we or our agent informs you otherwise in the confirmation of sale, this pricing supplement is being used in a market
resale transaction.



2 of 8
6/17/2013 4:00 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465913049640/...


We urge you to consult your investment, legal, tax, accounting and other advisers and to invest in the Notes only after you and your
advisors have carefully considered the suitability of an investment in the Notes in light of your particular circumstances.

Barclays Bank PLC has filed a registration statement (including a prospectus) with the SEC for the offering to which this pricing supplement
relates. Before you invest, you should read the prospectus dated August 31, 2010, the prospectus supplement dated May 27, 2011, and
other documents Barclays Bank PLC has filed with the SEC for more complete information about Barclays Bank PLC. and this offering.
Buyers should rely upon this pricing supplement, the prospectus, the prospectus supplement, and any relevant free writing prospectus for
complete details. You may get these documents and other documents Barclays Bank PLC has filed for free by visiting EDGAR on the SEC
website at www.sec.gov, and you may also access the prospectus and prospectus supplement through the links below:

·
Prospectus dated August 31, 2010:


http://www.sec.gov/Archives/edgar/data/312070/000119312510201448/df3asr.htm

·
Prospectus Supplement dated May 27, 2011:


http://www.sec.gov/Archives/edgar/data/312070/000119312511152766/d424b3.htm

Our Central Index Key, or CIK, on the SEC website is 1-10257.

Alternatively, Barclays Capital Inc. or any agent or dealer participating in this offering will arrange to send you this pricing supplement, the
prospectus, the prospectus supplement and any relevant free writing prospectus if you request it by calling your Barclays Capital Inc. sales
representative, such dealer or 1-888-227-2275 (Extension 2-3430). A copy of the prospectus may be obtained from Barclays Capital Inc.,
745 Seventh Avenue--Attn: US InvSol Support, New York, NY 10019.

We reserve the right to change the terms of, or reject any offer to purchase the Notes prior to their issuance. In the event of any changes to the terms
of the Notes, we wil notify you and you wil be asked to accept such changes in connection with your purchase. You may also choose to reject such
changes in which case we may reject your offer to purchase.

As used in this term sheet, the "Company," "we," "us," or "our" refers to Barclays Bank PLC.

3 of 8
6/17/2013 4:00 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465913049640/...

SELECTED RISK FACTORS

An investment in the Notes involves significant risks. You should read the risks summarized below in connection with, and the risks
summarized below are qualified by reference to, the risks described in more detail in the "Risk Factors" section beginning on page S-6 of
the prospectus supplement. We urge you to consult your investment, legal, tax, accounting and other advisers and to invest in the Notes
only after you and your advisors have carefully considered the suitability of an investment in the Notes in light of your particular
circumstances.

·
Issuer Credit Risk-- The Notes are our unsecured debt obligations, and are not, either directly or indirectly, an obligation of any third party.

Any payment to be made on the Notes, including any principal protection provided at maturity, depends on our ability to satisfy our obligations
as they come due. As a result, the actual and perceived creditworthiness of Barclays Bank PLC may affect the market value of the Notes and,
in the event we were to default on our obligations, you may not receive the principal protection or any other amounts owed to you under the
terms of the Notes.
·
Certain Built-In Costs Are Likely to Adversely Affect the Value of the Notes Prior to Maturity--While the payment at maturity described

in this pricing supplement is based on the ful principal amount of your Notes, the original issue price of the Notes includes the agent's
commission and the cost of hedging our obligations under the Notes through one or more of our affiliates. As a result, the price, if any, at which
Barclays Capital Inc. and other affiliates of Barclays Bank PLC wil be wil ing to purchase Notes from you in secondary market transactions wil
likely be lower than the price you paid for your Notes, and any sale prior to the Maturity Date could result in a substantial loss to you.
·
The Price You Paid for the Notes May Be Higher than the Prices Paid by Other Investors-- Barclays Capital Inc. proposes to offer the

Notes from time to time for sale to investors in one or more negotiated transactions, or otherwise, at prevailing market prices at the time of
sale, at prices related to then-prevailing prices, at negotiated prices, or otherwise. Accordingly, there is a risk that the price you paid for your
Notes wil be higher than the prices paid by other investors based on the date and time you made your purchase, from whom you purchased
the Notes, any related transaction costs, whether you hold your Notes in a brokerage account, a fiduciary or fee-based account or another type
of account and other market factors.
·
The Notes Will Be Subject to Redemption at Our Option -- We may redeem the Notes prior to the Maturity Date on any Interest Payment

Date, beginning on the date specified on the cover page hereof. If you intend to purchase the Notes, you must be wil ing to have your Notes
redeemed early. We are general y more likely to redeem the Notes during periods when we expect that interest wil accrue on the Notes at a
rate that is greater than that which we would pay on our traditional interest-bearing deposits or debt securities having a maturity equal to the
remaining term of the Notes. In contrast, we are general y less likely to redeem the Notes during periods when we expect interest to accrue on
the Notes at a rate that is less than that which we would pay on those instruments. If we redeem the Notes prior to the Maturity Date, accrued
interest wil be paid on the Notes until such early redemption, but you wil not receive any future interest payments from the Notes redeemed
and you may be unable to reinvest your proceeds from the redemption in an investment with a return that is as high as the return on the Notes
would have been if they had not been redeemed.
·
Potential Conflicts--We and our affiliates play a variety of roles in connection with the issuance of the Notes, including hedging our

obligations under the Notes. In performing these duties, the economic interests of our affiliates of ours are potential y adverse to your interests
as an investor in the Notes.

In addition, Barclays Wealth, the wealth management division of Barclays Capital Inc., may arrange for the sale of the Notes to certain of its
clients. In doing so, Barclays Wealth wil be acting as agent for Barclays Bank PLC and may receive compensation from Barclays Bank PLC in
the form of discounts and commissions. The role of Barclays Wealth as a provider of certain services to such customers and as agent for
Barclays Bank PLC in connection with the distribution of the Notes to investors may create a potential conflict of interest, which may be adverse
to such clients. Barclays Wealth is not acting as your agent or investment adviser, and is not representing you in any capacity with respect to
any purchase of Notes by you. Barclays Wealth is acting solely as agent for Barclays Bank PLC. If you are considering whether to invest in
the Notes through Barclays Wealth, we strongly urge you to seek independent financial and investment advice to assess the merits of such
investment.
·
Lack of Liquidity--The Notes wil not be listed on any securities exchange. Barclays Capital Inc. and other affiliates of Barclays Bank PLC

intend to make a secondary market for the Notes but are not required to do so, and may discontinue any such secondary market making at any
time, without notice. Barclays Capital Inc. may at any time hold unsold inventory, which may inhibit the development of a secondary market for
the Notes. Even if there is a secondary market, it may not provide enough liquidity to al ow you to trade or sel the Notes easily.

PS-1
4 of 8
6/17/2013 4:00 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465913049640/...

Because other dealers are not likely to make a secondary market for the Notes, the price at which you may be able to trade your Notes is
likely to depend on the price, if any, at which Barclays Capital Inc. and other affiliates of Barclays Bank PLC are wil ing to buy the Notes. The
Notes are not designed to be short-term trading instruments. Accordingly, you should be able and wil ing to hold your Notes to maturity.
·
Many Economic and Market Factors Will Impact the Value of the Notes--The value of the Notes wil be affected by a number of economic

and market factors that may either offset or magnify each other, including:

o
the time to maturity of the Notes;

o
interest and yield rates in the market general y;

o
a variety of economic, financial, political, regulatory or judicial events; and

o
our creditworthiness, including actual or anticipated downgrades in our credit ratings.


PS-2
5 of 8
6/17/2013 4:00 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465913049640/...

UNITED STATES FEDERAL INCOME TAX TREATMENT

The fol owing discussion supplements the discussion in the prospectus supplement under the heading "Certain U.S. Federal Income Tax Considerations"
and supersedes it to the extent inconsistent therewith. The fol owing discussion (in conjunction with the discussion in the prospectus supplement)
summarizes certain of the material U.S. federal income tax consequences of the purchase, beneficial ownership, and disposition of the Notes.

We intend to treat the Notes as indebtedness for U.S. federal income tax purposes and any reports to the Internal Revenue Service (the "IRS") and
U.S. holders wil be consistent with such treatment, and each holder wil agree to treat the Notes as indebtedness for U.S. federal income tax
purposes. The discussion that fol ows is based on this approach.

We intend to take the position that we are deemed to exercise the cal option prior to the first interest rate step-up (solely for purposes of determining
whether the Notes are issued with "original issue discount" for federal income tax purposes) and, if we do not exercise the cal option at such time, the
Notes wil be deemed to be reissued (solely for purposes of the original issue discount rules) at such time and immediately before each subsequent
interest rate step-up for their adjusted issue price. Accordingly, we intend to take the position that the Notes wil not be issued with original issue
discount for federal income tax purposes and that interest on the Notes wil be taxable to a U.S. holder as ordinary interest income at the time it
accrues or is received in accordance with the U.S. holder's normal method of accounting for tax purposes. See "Certain U.S. Federal Income Tax
Considerations--U.S. Federal Income Tax Treatment of the Notes as Indebtedness for U.S. Federal Income Tax Purposes--Notes Subject to Cal or
Put Options" in the prospectus supplement.

3.8% Medicare Tax On "Net Investment Income"

U.S. holders that are individuals, estates, and certain trusts are subject to an additional 3.8% tax on all or a portion of their "net investment income,"
which may include the interest payments and any gain realized with respect to the Notes, to the extent of their net investment income that, when added
to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a
surviving spouse), or $125,000 for a married individual filing a separate return. U.S. holders should consult their advisors with respect to the 3.8%
Medicare tax.

Information Reporting

Holders that are individuals (and, to the extent provided in future regulations, entities) may be required to disclose information about their Notes on IRS
Form 8938--"Statement of Specified Foreign Financial Assets" if the aggregate value of their Notes and their other "specified foreign financial assets"
exceeds $50,000. Significant penalties can apply if a holder fails to disclose its specified foreign financial assets. We urge you to consult your tax
advisor with respect to this and other reporting obligations with respect to your Notes.

Non-U.S. Holders

Barclays currently does not withhold on interest payments to non-U.S. holders in respect of instruments such as the Notes. However, if Barclays
determines that there is a material risk that it wil be required to withhold on any such payments, Barclays may withhold on such payments at a 30%
rate, unless non-U.S. holders have provided to Barclays an appropriate and valid Internal Revenue Service Form W-8. In addition, non-U.S. holders wil
be subject to the general rules regarding information reporting and backup withholding as described under the heading "Certain U.S. Federal Income
Tax Considerations--Information Reporting and Backup Withholding" in the accompanying prospectus supplement.

CERTAIN EMPLOYEE RETIREMENT INCOME SECURITY ACT CONSIDERATIONS

Your purchase of a Note in an Individual Retirement Account (an "IRA"), wil be deemed to be a representation and warranty by you, as a fiduciary of
the IRA and also on behalf of the IRA, that (i) neither the issuer, the placement agent nor any of their respective affiliates has or exercises any
discretionary authority or control or acts in a fiduciary capacity with respect to the IRA assets used to purchase the Note or renders investment advice
(within the meaning of Section 3(21)(A)(ii) of the Employee Retirement Income Security Act ("ERISA")) with respect to any such IRA assets and (ii) in
connection with the purchase of the Note, the IRA wil pay no more than "adequate consideration" (within the meaning of Section 408(b)(17) of ERISA)
and in connection with any redemption of the Note pursuant to its terms wil receive at least adequate consideration, and, in making the foregoing
representations and warranties, you have (x) applied sound business principles in determining whether fair market value wil be paid, and (y) made such
determination acting in good faith.

For additional ERISA considerations, see "Employee Retirement Income Security Act" in the prospectus supplement.

PS-3
6 of 8
6/17/2013 4:00 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465913049640/...

SUPPLEMENTAL PLAN OF DISTRIBUTION

We have agreed to sel to Barclays Capital Inc. (the "Agent"), and the Agent has agreed to purchase from us, the principal amount of the Notes, and at
the price, specified on the cover of this pricing supplement. The Agent is committed to take and pay for al of the Notes, if any are taken.

PS-4
7 of 8
6/17/2013 4:00 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465913049640/...






US$581,000
BARCLAYS BANK PLC

STEP-UP FIXED RATE CALLABLE NOTES DUE JUNE 19, 2023


GLOBAL MEDIUM-TERM NOTES, SERIES A




(TO PROSPECTUS DATED AUGUST 31, 2010, AND THE
PROSPECTUS SUPPLEMENT DATED MAY 27, 2011)



8 of 8
6/17/2013 4:00 PM